May, F;Guenther, M;Fastenmeier, K;Hartung, R
Improved high-frequency surgery for transurethral resection of the prostate: Report from a multicenter trial and identification of risk groups
J Urol
2003
169 Suppl.
4
467-467

Paul, R;Pfeifer, A;van Randenborgh, H;Kubler, H;Hartung, R
Renal cell cancer: Is there a true difference in prognosis of papillary and clear cell type carcinomas?
J Urol
2003
169 Suppl.
4
262-262

Weller, D;May, F;Rowett, D;Esterman, A;Pinnock, C;Nicholson, S;Doust, J;Silagy, C
Promoting better use of the PSA test in general practice: randomized controlled trial of educational strategies based on outreach visits and mailout.
Fam Pract
2003
20
6
655-61

Barba, M;Fastenmeier, K;Hartung, R
Electrocautery: principles and practice.
J Endourol
2003
17
8
541-55

May, F;Treiber, U;Hartung, R;Schwaibold, H
Significance of random bladder biopsies in superficial bladder cancer.
Eur Urol
2003
44
1
47-50

Treiber, U;Schwaibold, H;Berger, H;Hartung, R
[Pseudoaneurysm of a subsegmental renal artery after percutaneous nephrolitholapaxy]
Urologe A
2003
42
4
547-52

Weirich, G;Nährig, J;Treiber, U;Hartmann, C;Hartung, R;Höfler, H;Fend, F
Immunohistochemical assessment of a testicular tumor in a 63-year-old patient: proposal for an integrated clinicopathologic approach.
Appl Immunohistochem Mol Morphol
2003
11
1
96-100

Heit, A;Maurer, T;Hochrein, H;Bauer, S;Huster, KM;Busch, DH;Wagner, H
Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells.
J Immunol
2003
170
6
2802-5

Gerhard, MC;Zantl, N;Weirich, G;Schliep, S;Seiffert, B;Häcker, G
Functional evaluation of the apoptosome in renal cell carcinoma.
Br J Cancer
2003
89
11
2147-54

Hartwig, SE;Faustel, R;Weirich, G;Treiber, U;Wagenpfeil, S;Hartung, R
Over-expression of HER2/NEU correlates with tumor-specific survival of patients with urothelial carcinoma of the bladder
J Urol
2003
169 Suppl.
4
136-136